Extracorporeal shockwave therapy may be effective for intermittent lower limb claudication in peripheral artery disease (PAD) patients unable to engage in supervised exercise or who experienced little ...
Rochester, NY - Researchers are calling for beta-blocker treatment for patients with intermittent claudication, arguing that it is "old school" to avoid them in this high-risk group [1]. The new study ...
The pathophysiology of intermittent claudication is complex as it involves both a reduction in blood flow to peripheral tissues as well as changes in the metabolic function of skeletal muscle, caused ...
Researchers have found in the STRIDE trial that semaglutide significantly improved walking capacity in patients with ...
The patient was told that his symptoms are consistent with intermittent claudication, a clinical diagnosis given for muscle pain (ache, cramp, numbness or sense of fatigue), classically in the calf, ...
HAIFA, Israel September 16, 2013 — Pluristem Therapeutics Inc. (NASDAQCM: PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results